CYP51A1 antibody
Principal name
CYP51A1 antibody
Alternative names for CYP51A1 antibody
Cytochrome P450 51A1, CYP51, CYPLI, Cytochrome P450LI, Sterol 14-alpha demethylase, Lanosterol 14-alpha demethylase
Ncbi ID
9606, NM_000786, ABM85421.1, NP_000777, NP_000777.1, NM_012941
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB)
Background of CYP51A1 antibody
- Kit Component:
- - KN207078G1, CYP51A1 gRNA vector 1 in pCas-Guide vector
- KN207078G2, CYP51A1 gRNA vector 2 in pCas-Guide vector
- KN207078D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual

Human HeLa; WB Suggested Anti-CYP51A1 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: Hela cell lysate; CYP51A1 antibody - N-terminal region (ARP60153_P050) in Human HeLa cells using Western Blot

WB Suggested Anti-CYP51A1 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:312500; Positive Control: Hela cell lysate
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP307078 | CYP51A1 |
||||
| Recombinant protein of human cytochrome P450, family 51, subfamily A, polypeptide 1 (CYP51A1) | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR207058L2V | Lenti ORF particles, Cyp51 (GFP-tagged ORF) - Rat cytochrome P450, subfamily 51 (Cyp51), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,190.00
|
|
| OriGene Technologies, Inc. | ||
| RR207058L1V | Lenti ORF particles, Cyp51 (Myc-DDK-tagged ORF) - Rat cytochrome P450, subfamily 51 (Cyp51), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,070.00
|
|
| OriGene Technologies, Inc. | ||








